224 related articles for article (PubMed ID: 16582513)
21. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
Jodele S; Blavier L; Yoon JM; DeClerck YA
Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570
[TBL] [Abstract][Full Text] [Related]
22. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.
Chen MH; Cui SX; Cheng YN; Sun LR; Li QB; Xu WF; Ward SG; Tang W; Qu XJ
Anticancer Drugs; 2008 Nov; 19(10):957-65. PubMed ID: 18827560
[TBL] [Abstract][Full Text] [Related]
23. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
Masson V
Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
[TBL] [Abstract][Full Text] [Related]
24. Collagenases in cancer.
Ala-aho R; Kähäri VM
Biochimie; 2005; 87(3-4):273-86. PubMed ID: 15781314
[TBL] [Abstract][Full Text] [Related]
25. Strategies for MMP inhibition in cancer: innovations for the post-trial era.
Overall CM; López-Otín C
Nat Rev Cancer; 2002 Sep; 2(9):657-72. PubMed ID: 12209155
[TBL] [Abstract][Full Text] [Related]
26. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
Poincloux R; Lizárraga F; Chavrier P
J Cell Sci; 2009 Sep; 122(Pt 17):3015-24. PubMed ID: 19692588
[TBL] [Abstract][Full Text] [Related]
27. [Matrix metalloproteinase in human gastric carcinoma].
Adachi Y; Itoh F; Imai K
Nihon Rinsho; 2001 Apr; 59 Suppl 4():107-12. PubMed ID: 11424366
[No Abstract] [Full Text] [Related]
28. Tube travel: the role of proteases in individual and collective cancer cell invasion.
Friedl P; Wolf K
Cancer Res; 2008 Sep; 68(18):7247-9. PubMed ID: 18794108
[TBL] [Abstract][Full Text] [Related]
29. The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors.
Peterson JT
Cardiovasc Res; 2006 Feb; 69(3):677-87. PubMed ID: 16413004
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinases: a multifunctional group of molecules.
Murray GI
J Pathol; 2001 Sep; 195(2):135-7. PubMed ID: 11592090
[TBL] [Abstract][Full Text] [Related]
31. [Role of extracellular matrix degradation enzyme for glioma invasion].
Nakada M
Nihon Rinsho; 2005 Sep; 63 Suppl 9():55-60. PubMed ID: 16201500
[No Abstract] [Full Text] [Related]
32. Chemically modified tetracyclines as inhibitors of matrix metalloproteinases.
Acharya MR; Venitz J; Figg WD; Sparreboom A
Drug Resist Updat; 2004 Jun; 7(3):195-208. PubMed ID: 15296861
[TBL] [Abstract][Full Text] [Related]
33. Biological activity and clinical implications of the matrix metalloproteinases.
Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
[TBL] [Abstract][Full Text] [Related]
34. Influence of persistent canine distemper virus infection on expression of RECK, matrix-metalloproteinases and their inhibitors in a canine macrophage/monocytic tumour cell line (DH82).
Puff C; Krudewig C; Imbschweiler I; Baumgärtner W; Alldinger S
Vet J; 2009 Oct; 182(1):100-7. PubMed ID: 18684651
[TBL] [Abstract][Full Text] [Related]
35. A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents.
Ribba B; Saut O; Colin T; Bresch D; Grenier E; Boissel JP
J Theor Biol; 2006 Dec; 243(4):532-41. PubMed ID: 16930628
[TBL] [Abstract][Full Text] [Related]
36. [Significance of matrix metalloproteinases and their ihhibitors in norm, oncology, and oncological hematology].
Gaĭdamaka NV; Parovichnikova EN; Zavalishina LE; Savchenko VG; Frank GA
Ter Arkh; 2009; 81(7):91-6. PubMed ID: 19708583
[TBL] [Abstract][Full Text] [Related]
37. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
[TBL] [Abstract][Full Text] [Related]
38. Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition.
Taras D; Blanc JF; Rullier A; Dugot-Senant N; Laurendeau I; Bièche I; Pines M; Rosenbaum J
Neoplasia; 2006 Apr; 8(4):312-8. PubMed ID: 16756723
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo.
Kapischke M; Fischer T; Tiessen K; Tschesche H; Bruch HP; Kalthoff H; Kruse ML
Int J Oncol; 2008 Jan; 32(1):273-82. PubMed ID: 18097568
[TBL] [Abstract][Full Text] [Related]
40. Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression.
Lee SO; Jeong YJ; Kim M; Kim CH; Lee IS
Biochem Biophys Res Commun; 2008 Feb; 366(4):1019-24. PubMed ID: 18088599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
